Who makes EHP-101 Liquid multiple doses?

EHP-101 Liquid multiple doses is developed by Emerald Health Pharmaceuticals.

What development phase is EHP-101 Liquid multiple doses in?

EHP-101 Liquid multiple doses is in Phase 1.

Last reviewed 2026-05-14 · How we verify

EHP-101 Liquid multiple doses

Emerald Health Pharmaceuticals · Phase 1 active Small molecule

At a glance

Generic name	EHP-101 Liquid multiple doses
Sponsor	Emerald Health Pharmaceuticals
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

EHP-101 Liquid multiple doses CI brief — competitive landscape report
EHP-101 Liquid multiple doses updates RSS · CI watch RSS
Emerald Health Pharmaceuticals portfolio CI